Chromitope Sodium

   
Google
 
Web NewDrugInformation.com

Chromitope Sodium


Drug - Chromitope Sodium
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Sodium Chromate, Cr-51
Multiple ingredients are in alphabetical order.

Strength - 200uCi/ML
The potency of the active ingredient(s), Sodium Chromate, Cr-51. May repeat for multiple part products.

Applicant - BRACCO
The firm name holding legal responsibility for Chromitope Sodium. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 013993
The FDA assigned number to Chromitope Sodium. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Chromitope Sodium. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Chromitope Sodium was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Chromitope Sodium. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Chromitope Sodium is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bracco Diagnostics Inc
The full name of the firm holding legal responsibility for the new application of Chromitope Sodium.

Chromitope Sodium